TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2014

Pharmacokinetics, safety, and 48-week efficacy of oral raltegravir in HIV-1-infected children aged 2 through 18 years.

Sharon Nachman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.